Cost-effectiveness and resource use of implementing MRI-guided NACT in ER-positive/HER2-negative breast cancers in The Netherlands
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Steuten, Lotte M. G.
Rigter, Lisanne S.
van Harten, Wim H.
Funding for this research was provided by:
Center for Translational Molecular Medicine (NL) (03O-104)